Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.

NCT01291017 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Florida